The study was supervised by Limor Ben-Zvi together with Dr. Shulim Spiegel from the oncology research department and Dr. Ari Rafael, Director of the Oncology day care unit.
Experimental cancer treatment with nitric oxide
The research division of the oncology department at the Ichilov medical center was selected as the first in the world to conduct human trials of a new experimental therapy based on the direct delivery of nitric oxide into tumor tissue. The development of this technology belongs to the biotechnology company Beyond Cancer, and the approach is aimed at increasing the effectiveness of cancer cell targeting while minimizing the impact on healthy tissues. This could reduce unpleasant side effects and significantly simplify the course of therapy.
07, Feb 2026
Advantages of the oncology center at Ichilov
The choice of this particular research division of the oncology center was not accidental. The Ichilov clinic has a recognized international reputation for conducting Phase I clinical trials, where patient safety and strict protocol accuracy are of paramount importance.
In addition, the research division of the Ichilov oncology center has highly qualified engineering and medical teams capable of providing the complex technical infrastructure required to implement innovative treatment methods.
The clinic is also widely known for its modern, established cancer treatment approaches, which for many years have demonstrated high survival rates and improved quality of life for patients. At Ichilov, chemotherapy, immunotherapy, targeted therapy, and radiation therapy protocols are successfully applied, based on international clinical guidelines and a personalized approach to each patient. Great emphasis is placed on precise diagnostics, molecular tumor profiling, and the selection of therapy that takes into account the individual characteristics of the disease.
The oncology center treats a wide range of malignant diseases, including breast, lung, gastrointestinal, and prostate cancers, hematologic malignancies, and rare forms of cancer. Multidisciplinary medical teams develop comprehensive treatment plans, combining several methods to achieve the best possible outcomes. Thanks to this, Ichilov remains not only a platform for breakthrough research, but also a clinic with proven, effective, and trusted treatment methods for patients from all over the world.
You can learn all the details directly from the clinic’s specialists at the following link
It is precisely this combination of clinical experience, scientific expertise, and technological capabilities that made the oncology center’s research division the first site in the world to conduct human trials of this promising therapy.
